These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 9004229)

  • 1. The leader peptide is essential for the post-translational modification of the DNA-gyrase inhibitor microcin B17.
    Madison LL; Vivas EI; Li YM; Walsh CT; Kolter R
    Mol Microbiol; 1997 Jan; 23(1):161-8. PubMed ID: 9004229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The maturation pathway of microcin B17, a peptide inhibitor of DNA gyrase.
    Yorgey P; Davagnino J; Kolter R
    Mol Microbiol; 1993 Aug; 9(4):897-905. PubMed ID: 8231817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From peptide precursors to oxazole and thiazole-containing peptide antibiotics: microcin B17 synthase.
    Li YM; Milne JC; Madison LL; Kolter R; Walsh CT
    Science; 1996 Nov; 274(5290):1188-93. PubMed ID: 8895467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutational analysis of posttranslational heterocycle biosynthesis in the gyrase inhibitor microcin B17: distance dependence from propeptide and tolerance for substitution in a GSCG cyclizable sequence.
    Sinha Roy R; Belshaw PJ; Walsh CT
    Biochemistry; 1998 Mar; 37(12):4125-36. PubMed ID: 9521734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor.
    Yorgey P; Lee J; Kördel J; Vivas E; Warner P; Jebaratnam D; Kolter R
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4519-23. PubMed ID: 8183941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics and regioselectivity of peptide-to-heterocycle conversions by microcin B17 synthetase.
    Belshaw PJ; Roy RS; Kelleher NL; Walsh CT
    Chem Biol; 1998 Jul; 5(7):373-84. PubMed ID: 9662507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranslational heterocyclization of cysteine and serine residues in the antibiotic microcin B17: distributivity and directionality.
    Kelleher NL; Hendrickson CL; Walsh CT
    Biochemistry; 1999 Nov; 38(47):15623-30. PubMed ID: 10569947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro characterization of DNA gyrase inhibition by microcin B17 analogs with altered bisheterocyclic sites.
    Zamble DB; Miller DA; Heddle JG; Maxwell A; Walsh CT; Hollfelder F
    Proc Natl Acad Sci U S A; 2001 Jul; 98(14):7712-7. PubMed ID: 11427730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Architecture of Microcin B17 Synthetase: An Octameric Protein Complex Converting a Ribosomally Synthesized Peptide into a DNA Gyrase Poison.
    Ghilarov D; Stevenson CEM; Travin DY; Piskunova J; Serebryakova M; Maxwell A; Lawson DM; Severinov K
    Mol Cell; 2019 Feb; 73(4):749-762.e5. PubMed ID: 30661981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cofactor requirements and reconstitution of microcin B17 synthetase: a multienzyme complex that catalyzes the formation of oxazoles and thiazoles in the antibiotic microcin B17.
    Milne JC; Roy RS; Eliot AC; Kelleher NL; Wokhlu A; Nickels B; Walsh CT
    Biochemistry; 1999 Apr; 38(15):4768-81. PubMed ID: 10200165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents.
    Collin F; Maxwell A
    J Mol Biol; 2019 Aug; 431(18):3400-3426. PubMed ID: 31181289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of the microcin B17 propeptide in substrate recognition: solution structure and mutational analysis of McbA1-26.
    Roy RS; Kim S; Baleja JD; Walsh CT
    Chem Biol; 1998 Apr; 5(4):217-28. PubMed ID: 9545435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expressed protein ligation to probe regiospecificity of heterocyclization in the peptide antibiotic microcin B17.
    Roy RS; Allen O; Walsh CT
    Chem Biol; 1999 Nov; 6(11):789-99. PubMed ID: 10574779
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for the role of DNA strand passage in the mechanism of action of microcin B17 on DNA gyrase.
    Pierrat OA; Maxwell A
    Biochemistry; 2005 Mar; 44(11):4204-15. PubMed ID: 15766248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of full length and truncated microcin B17 analogues as DNA gyrase poisons.
    Thompson RE; Collin F; Maxwell A; Jolliffe KA; Payne RJ
    Org Biomol Chem; 2014 Mar; 12(10):1570-8. PubMed ID: 24448886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The highly conserved TldD and TldE proteins of Escherichia coli are involved in microcin B17 processing and in CcdA degradation.
    Allali N; Afif H; Couturier M; Van Melderen L
    J Bacteriol; 2002 Jun; 184(12):3224-31. PubMed ID: 12029038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A major portion of DNA gyrase inhibitor microcin B17 undergoes an N,O-peptidyl shift during synthesis.
    Ghilarov D; Serebryakova M; Shkundina I; Severinov K
    J Biol Chem; 2011 Jul; 286(30):26308-18. PubMed ID: 21628468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Post-translational heterocyclic backbone modifications in the 43-peptide antibiotic microcin B17. Structure elucidation and NMR study of a 13C,15N-labelled gyrase inhibitor.
    Bayer A; Freund S; Jung G
    Eur J Biochem; 1995 Dec; 234(2):414-26. PubMed ID: 8536683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expansion of ribosomally produced natural products: a nitrile hydratase- and Nif11-related precursor family.
    Haft DH; Basu MK; Mitchell DA
    BMC Biol; 2010 May; 8():70. PubMed ID: 20500830
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ATP/GTP hydrolysis is required for oxazole and thiazole biosynthesis in the peptide antibiotic microcin B17.
    Milne JC; Eliot AC; Kelleher NL; Walsh CT
    Biochemistry; 1998 Sep; 37(38):13250-61. PubMed ID: 9748332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.